Transcriptomics

Dataset Information

0

Lenvatinib-treated Tregs exhibit superior anti-inflammation effect in autoimmune diseases


ABSTRACT: Adoptive transfer of regulatory T cells (Tregs) holds promise for treating autoimmune diseases (AIDs) such as inflammatory bowel disease (IBD), psoriasis, and rosacea, but its clinical application is hampered by the difficulty of generating sufficient stable and functional Tregs. Here, we identified a novel immunomodulatory function of the multi-kinase inhibitor lenvatinib (Lenv) in specifically promoting Treg differentiation without affecting other T helper cell subsets. Mechanistically, Lenv inhibited VEGFR/AKT signaling and activated Foxo1, thereby enhancing Foxp3 expression. Adoptive transfer of Lenv-treated Tregs (Lenv-Tregs) in murine models of IBD, psoriasis, and rosacea achieved superior alleviation of clinical symptoms and inflammation compared with vehicle-treated Tregs (Ctrl-Tregs). Our findings uncover a novel role for Lenv in Treg differentiation and provide a robust strategy to generate a considerable number of highly potent immunosuppressive Tregs for cell-based therapy against AIDs.

ORGANISM(S): Mus musculus

PROVIDER: GSE328467 | GEO | 2026/07/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2026-07-30 | GSE328751 | GEO
2022-07-28 | GSE206775 | GEO
2015-05-19 | E-GEOD-68991 | biostudies-arrayexpress
2023-10-09 | GSE244616 | GEO
2026-04-23 | GSE328515 | GEO
2015-04-29 | E-GEOD-64247 | biostudies-arrayexpress
2024-03-22 | GSE220447 | GEO
2021-10-15 | GSE185854 | GEO
2025-07-25 | GSE303685 | GEO
2021-04-01 | GSE166713 | GEO